|
|
||||||||
Physiological Reviews, Vol 77, 517-544, Copyright © 1997 by American Physiological Society
JOURNAL ARTICLE |
C. S. Lieber
Alcohol Research and Treatment Center, Bronx Department of Veterans Affairs Medical Center, New York, USA.
The role of the microsomal ethanol-oxidizing system (MEOS) in hepatic ethanol metabolism is reviewed, with focus on its constitutive, ethanol-inducible cytochrome P-4502E1 (2E1). The MEOS was purified and reconstituted using 2E1, phospholipids, and cytochrome P-450 reductase and shown to oxidize ethanol to acetaldehyde, mainly as a monooxygenase and secondarily via hydroxyl radicals, with transcriptional and posttranscriptional regulation. Polymorphism of 2E1 was recognized, and enzymology (including cofactors, role of lipids, inducers, and inhibitors) as well as cellular and tissue distribution were chartered. Physiological functions involve lipid metabolism and ketone utilization in starvation, obesity, and diabetes. The most significant role of 2E1 is its adaptive response to high blood ethanol levels with a corresponding acceleration of ethanol metabolism. The associated free radical production, however, contributes to liver injury in the alcoholic. Most importantly, 2E1 has a unique capacity to activate many xenobiotics (85 of which are listed) to hepatotoxic or carcinogenic products. Induction of 2E1 also results in enhanced production of acetaldehyde, a highly reactive and toxic metabolite. The proliferation of the endoplasmic reticulum associated with 2E1 induction is also accompanied by enhanced activity of other cytochrome P-450s, resulting in accelerated metabolism of, and tolerance to, other drugs, as well as increased degradation of retinol and its hepatic depletion. Some substrates and metabolites, however, are innocuous and may eventually be used as markers of heavy drinking. Recently discovered effective 2E1 inhibitors also have great therapeutic potential.
This article has been cited by other articles:
![]() |
M. Morita, S. Tabata, O. Tajima, G. Yin, H. Abe, and S. Kono Genetic Polymorphisms of CYP2E1 and Risk of Colorectal Adenomas in the Self Defense Forces Health Study Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1800 - 1807. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Y. Ahn, S. K. Bae, Y. S. Jung, I. Lee, Y. C. Kim, M. G. Lee, and W. G. Shin Pharmacokinetic Parameters of Chlorzoxazone and Its Main Metabolite, 6-Hydroxychlorzoxazone, after Intravenous and Oral Administration of Chlorzoxazone to Liver Cirrhotic Rats with Diabetes Mellitus Drug Metab. Dispos., July 1, 2008; 36(7): 1233 - 1241. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chen, K. W. Krausz, J. R. Idle, and F. J. Gonzalez Identification of Novel Toxicity-associated Metabolites by Metabolomics and Mass Isotopomer Analysis of Acetaminophen Metabolism in Wild-type and Cyp2e1-null Mice J. Biol. Chem., February 22, 2008; 283(8): 4543 - 4559. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dey and A. I. Cederbaum Geldanamycin, an Inhibitor of Hsp90, Potentiates Cytochrome P4502E1-Mediated Toxicity in HepG2 Cells J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1391 - 1399. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bai and A. I. Cederbaum Adenovirus-Mediated Expression of CYP2E1 Produces Liver Toxicity in Mice Toxicol. Sci., June 1, 2006; 91(2): 365 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Joshi and R. F. Tyndale INDUCTION AND RECOVERY TIME COURSE OF RAT BRAIN CYP2E1 AFTER NICOTINE TREATMENT Drug Metab. Dispos., April 1, 2006; 34(4): 647 - 652. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bai and A. I. Cederbaum Overexpression of CYP2E1 in Mitochondria Sensitizes HepG2 Cells to the Toxicity Caused by Depletion of Glutathione J. Biol. Chem., February 24, 2006; 281(8): 5128 - 5136. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lu and A. I. Cederbaum Cisplatin-Induced Hepatotoxicity Is Enhanced by Elevated Expression of Cytochrome P450 2E1 Toxicol. Sci., February 1, 2006; 89(2): 515 - 523. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Park, K.-A. Kim, P.-W. Park, and J.-M. Ha Effect of High-Dose Aspirin on CYP2E1 Activity in Healthy Subjects Measured Using Chlorzoxazone as a Probe J. Clin. Pharmacol., January 1, 2006; 46(1): 109 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chilakapati, K. Shankar, M. C. Korrapati, R. A. Hill, and H. M. Mehendale SATURATION TOXICOKINETICS OF THIOACETAMIDE: ROLE IN INITIATION OF LIVER INJURY Drug Metab. Dispos., December 1, 2005; 33(12): 1877 - 1885. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Kruger, J. W. Blum, and D. L. Greger Expression of Nuclear Receptor and Target Genes in Liver and Intestine of Neonatal Calves Fed Colostrum and Vitamin A J Dairy Sci, November 1, 2005; 88(11): 3971 - 3981. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Soucek, P. Anzenbacher, I. Skoumalova, and M. Dvorak Expression of Cytochrome P450 Genes in CD34+ Hematopoietic Stem and Progenitor Cells Stem Cells, September 1, 2005; 23(9): 1417 - 1422. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Baranova, E. Anzenbacherova, P. Anzenbacher, and P. Soucek MINIPIG CYTOCHROME P450 2E1: COMPARISON WITH HUMAN ENZYME Drug Metab. Dispos., June 1, 2005; 33(6): 862 - 865. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. XU, M. A. LEO, and C. S. LIEBER DLPC ATTENUATES ALCOHOL-INDUCED CYTOTOXICITY IN HEPG2 CELLS EXPRESSING CYP2E1 Alcohol Alcohol., May 1, 2005; 40(3): 172 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cheung, A.-M. Yu, J. M. Ward, K. W. Krausz, T. E. Akiyama, L. Feigenbaum, and F. J. Gonzalez THE CYP2E1-HUMANIZED TRANSGENIC MOUSE: ROLE OF CYP2E1 IN ACETAMINOPHEN HEPATOTOXICITY Drug Metab. Dispos., March 1, 2005; 33(3): 449 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Iohom, D. Fitzgerald, and A. J. Cunningham Principles of pharmacogenetics--implications for the anaesthetist Br. J. Anaesth., September 1, 2004; 93(3): 440 - 450. [Full Text] [PDF] |
||||
![]() |
C. S Lieber, M. A Leo, K. M Mak, Y. Xu, Q. Cao, C. Ren, A. Ponomarenko, and L. M DeCarli Model of nonalcoholic steatohepatitis Am. J. Clinical Nutrition, March 1, 2004; 79(3): 502 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Sultatos, G. M. Pastino, C. A. Rosenfeld, and E. J. Flynn Incorporation of the Genetic Control of Alcohol Dehydrogenase into a Physiologically Based Pharmacokinetic Model for Ethanol in Humans Toxicol. Sci., March 1, 2004; 78(1): 20 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Raza, S. K. Prabu, M.-A. Robin, and N. G. Avadhani Elevated Mitochondrial Cytochrome P450 2E1 and Glutathione S-Transferase A4-4 in Streptozotocin-Induced Diabetic Rats: Tissue-Specific Variations and Roles in Oxidative Stress Diabetes, January 1, 2004; 53(1): 185 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Handschin and U. A. Meyer Induction of Drug Metabolism: The Role of Nuclear Receptors Pharmacol. Rev., December 1, 2003; 55(4): 649 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Seth, M. A. Leo, P. H. McGuinness, C. S. Lieber, Y. Brennan, R. Williams, X. M. Wang, G. W. McCaughan, M. D. Gorrell, and P. S. Haber Gene Expression Profiling of Alcoholic Liver Disease in the Baboon (Papio hamadryas) and Human Liver Am. J. Pathol., December 1, 2003; 163(6): 2303 - 2317. [Abstract] [Full Text] |
||||
![]() |
A. L. Micu, S. Miksys, E. M. Sellers, D. R. Koop, and R. F. Tyndale Rat Hepatic CYP2E1 Is Induced by Very Low Nicotine Doses: An Investigation of Induction, Time Course, Dose Response, and Mechanism J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 941 - 947. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Moncion, N. T. Truong, A. Garrone, P. Beaune, R. Barouki, and I. de Waziers Identification of a 16-Nucleotide Sequence That Mediates Post-transcriptional Regulation of Rat CYP2E1 by Insulin J. Biol. Chem., November 22, 2002; 277(48): 45904 - 45910. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S Lieber S-Adenosyl-L-methionine: its role in the treatment of liver disorders Am. J. Clinical Nutrition, November 1, 2002; 76 (5): 1183S - 1187S. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lejus, C. Le Roux, E. Legendre, M. Renaudin, H. L. Boiteau, and M. Pinaud Fluoride excretion in children after sevoflurane anaesthesia Br. J. Anaesth., November 1, 2002; 89(5): 693 - 696. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. R. Simon, J. Fortune, M. Iwahashi, and E. Sutherland Sexual dimorphic expression of ADH in rat liver: importance of the hypothalamic-pituitary-liver axis Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G646 - G655. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fisher, A. Halladay, N. Ramasubramaniam, J. C. Petrucci, D. Dagounis, A. Sekowski, J. V. Martin, and G. C. Wagner Liver Fat and Plasma Ethanol Are Sharply Lower in Rats Fed Ethanol in Conjunction with High Carbohydrate Compared with High Fat Diets J. Nutr., September 1, 2002; 132(9): 2732 - 2736. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Chung, S. H. Kim, M. G. Lee, and S. G. Kim Increase in Urea in Conjunction with L-Arginine Metabolism in the Liver Leads to Induction of Cytochrome P450 2E1 (CYP2E1): The Role of Urea in CYP2E1 Induction by Acute Renal Failure Drug Metab. Dispos., June 1, 2002; 30(6): 739 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mari, J. Bai, and A. I. Cederbaum Adenovirus-Mediated Overexpression of Catalase in the Cytosolic or Mitochondrial Compartment Protects against Toxicity Caused by Glutathione Depletion in HepG2 Cells Expressing CYP2E1 J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 111 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhou, X. Sun, and Y. James Kang Metallothionein Protection against Alcoholic Liver Injury through Inhibition of Oxidative Stress Experimental Biology and Medicine, March 1, 2002; 227(3): 214 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. MATO, F. J. CORRALES, S. C. LU, and M. A. AVILA S-Adenosylmethionine: a control switch that regulates liver function FASEB J, January 1, 2002; 16(1): 15 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Howard, A. L. Micu, E. M. Sellers, and R. F. Tyndale Low Doses of Nicotine and Ethanol Induce CYP2E1 and Chlorzoxazone Metabolism in Rat Liver J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 542 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Nanji, K. Jokelainen, G. L. Tipoe, A. Rahemtulla, and A. J. Dannenberg Dietary Saturated Fatty Acids Reverse Inflammatory and Fibrotic Changes in Rat Liver Despite Continued Ethanol Administration J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 638 - 644. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Fontaine, P. B. Hoyer, J. R. Halpert, and I. G. Sipes Role of Induction of Specific Hepatic Cytochrome P450 Isoforms in Epoxidation of 4-Vinylcyclohexene Drug Metab. Dispos., September 1, 2001; 29(9): 1236 - 1242. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Sidhu, F. Liu, S. M. Boyle, and C. J. Omiecinski PI3K Inhibitors Reverse the Suppressive Actions of Insulin on CYP2E1 Expression by Activating Stress-Response Pathways in Primary Rat Hepatocytes Mol. Pharmacol., April 16, 2001; 59(5): 1138 - 1146. [Abstract] [Full Text] |
||||
![]() |
H. C. Chung, S. H. Sung, J. S. Kim, Y. C. Kim, and S. G. Kim Lack of Cytochrome P450 2E1 (CYP2E1) Induction in the Rat Liver by Starvation without Coprophagy Drug Metab. Dispos., March 1, 2001; 29(3): 213 - 216. [Abstract] [Full Text] |
||||
![]() |
T. R. Fennell, J. P. MacNeela, R. W. Morris, M. Watson, C. L. Thompson, and D. A. Bell Hemoglobin Adducts from Acrylonitrile and Ethylene Oxide in Cigarette Smokers: Effects of Glutathione S-Transferase T1-Null and M1-Null Genotypes Cancer Epidemiol. Biomarkers Prev., July 1, 2000; 9(7): 705 - 712. [Abstract] [Full Text] |
||||
![]() |
S. S. Percival and C. A. Sims Wine Modifies the Effects of Alcohol on Immune Cells of Mice1-3 J. Nutr., May 1, 2000; 130(5): 1091 - 1094. [Abstract] [Full Text] |
||||
![]() |
A. Banerjee, T. A. Kocarek, and R. F. Novak Identification of a Ubiquitination-Target/Substrate-Interaction Domain of Cytochrome P-450 (CYP) 2E1 Drug Metab. Dispos., February 1, 2000; 28(2): 118 - 124. [Abstract] [Full Text] |
||||
![]() |
M. D. J. Kerai, C. J. Waterfield, S. H. Kenyon, D. S. Asker, and J. A. Timbrell REVERSAL OF ETHANOL-INDUCED HEPATIC STEATOSIS AND LIPID PEROXIDATION BY TAURINE: A STUDY IN RATS Alcohol Alcohol., July 1, 1999; 34(4): 529 - 541. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Watson, S. M. Poloyac, G. Howard, and R. A. Blouin Effect of Leptin on Cytochrome P-450, Conjugation, and Antioxidant Enzymes in the ob/ob Mouse Drug Metab. Dispos., June 1, 1999; 27(6): 695 - 700. [Abstract] [Full Text] |
||||
![]() |
E. D. Kharasch, D. C. Hankins, C. Jubert, K. E. Thummel, and J. K. Taraday Lack of Single-Dose Disulfiram Effects on Cytochrome P-450 2C9, 2C19, 2D6, and 3A4 Activities: Evidence for Specificity Toward P-450 2E1 Drug Metab. Dispos., June 1, 1999; 27(6): 717 - 723. [Abstract] [Full Text] |
||||
![]() |
M. R. Brzezinski, H. Boutelet-Bochan, R. E. Person, A. G. Fantel, and M. R. Juchau Catalytic Activity and Quantitation of Cytochrome P-450 2E1 in Prenatal Human Brain J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1648 - 1653. [Abstract] [Full Text] |
||||
![]() |
J.-Y. Huan and D. R. Koop Tightly Regulated and Inducible Expression of Rabbit Cyp2e1 Using A Tetracycline-Controlled Expression System Drug Metab. Dispos., April 1, 1999; 27(4): 549 - 554. [Abstract] [Full Text] |
||||
![]() |
K. Sakurai and A. I. Cederbaum Oxidative Stress and Cytotoxicity Induced by Ferric-Nitrilotriacetate in HepG2 Cells That Express Cytochrome P450 2E1 Mol. Pharmacol., December 1, 1998; 54(6): 1024 - 1035. [Abstract] [Full Text] |
||||
![]() |
N. Nieto, P. Greenwel, S. L. Friedman, F. Zhang, A. J. Dannenberg, and A. I. Cederbaum Ethanol and Arachidonic Acid Increase alpha 2(I) Collagen Expression in Rat Hepatic Stellate Cells Overexpressing Cytochrome P450 2E1. ROLE OF H2O2 AND CYCLOOXYGENASE-2 J. Biol. Chem., June 23, 2000; 275(26): 20136 - 20145. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mari and A. I. Cederbaum CYP2E1 Overexpression in HepG2 Cells Induces Glutathione Synthesis by Transcriptional Activation of gamma -Glutamylcysteine Synthetase J. Biol. Chem., May 12, 2000; 275(20): 15563 - 15571. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |